CCL2 and glioblastoma: A recent study has shown that the long non-coding RNA (LncRNA) H19 encodes an immune-related protein, H19-IRP, which promotes immunosuppression in glioblastoma multiforme (GBM) by binding to and activating the transcription of the CCL2 and galactaglutinin-9 promoters.